Pfm Health Sciences, LP Clovis Oncology, Inc. Call Options Transaction History

Pfm Health Sciences, LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $8.72 Million - $24.5 Million	-750,200 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$29.37 - $49.48 $1.01 Million - $1.71 Million	-34,500 Reduced 4.4%	750,200 $22 Million
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $33 Million - $49 Million	784,700 New	784,700 $35.7 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.